Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evidence for a second receptor binding site on human prolactin

V Goffin1, I Struman, V Mainfroid

  • 1Laboratory of Molecular Biology and Genetic Engineering, University of Liège, Sart-Tilman, Belgium.

The Journal of Biological Chemistry
|December 23, 1994
PubMed
Summary

Researchers investigated a second receptor binding site on human prolactin (hPRL) using mutagenesis. Mutants altering the helix 1-helix 3 interface showed reduced activity, supporting the site

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Idiopathic pulmonary fibrosis : from biomarkers to new therapeutic areas].

Revue medicale de Liege·2021
Same author

[TMPRSS2-Erg/AR-V7: Prognostic value of tests in urine and biopsy rince material in prostate cancer].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2020
Same author

Prolactin decreases LPS-induced inflammatory cytokines by inhibiting TLR-4/NFκB signaling in the human placenta.

Molecular human reproduction·2019
Same author

Altered epigenetic features in circulating nucleosomes in idiopathic pulmonary fibrosis.

Clinical epigenetics·2017
Same author

Microwave corneosurfametry: a minute assessment of the skin compatibility of surfactant-containing products.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·2016
Same author

Comparative surfactant reactivity of canine and human stratum corneum: a plea for the use of the corneosurfametry bioassay.

Alternatives to laboratory animals : ATLA·2014

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Hormone Receptor Interactions

Background:

  • Human prolactin (hPRL) is a pituitary hormone crucial for lactation and other functions.
  • Understanding hPRL's receptor interaction is key to its biological activity.
  • Previous models suggested sequential binding, but the precise nature of hPRL binding sites remained unclear.

Purpose of the Study:

  • To investigate the existence and functional significance of a second receptor binding site on human prolactin (hPRL).
  • To elucidate the structural basis of hPRL-receptor interactions and potential self-antagonism.
  • To propose a refined model for hPRL binding to its receptor.

Main Methods:

  • Site-directed mutagenesis of hPRL helices 1 and 3.
  • Bioactivity assays using Nb2 cell proliferation.

Related Experiment Videos

  • Analysis of mutant hPRL analogs for agonistic, antagonistic, and self-antagonistic properties.
  • Comparative analysis with human growth hormone (hGH) binding models.

    • Main Results:

    • Mutations in helices 1 and 3 did not abolish bioactivity, indicating these residues are not solely essential for binding.
    • Replacing small residues near the helix 1-helix 3 interface with bulky ones (Arg/Trp) yielded mutants with weak agonistic properties.
    • Mutants altered at the proposed second binding site exhibited self-antagonism, unlike native hPRL or site 1 mutants.
    • Native hPRL did not show self-inhibition even at high concentrations.

    Conclusions:

    • The findings support the hypothesis of a second receptor binding site for hPRL located between helices 1 and 3.
    • hPRL likely binds sequentially to two receptor molecules, similar to hGH.
    • Unlike hGH, both hPRL binding sites appear to have similar affinities, preventing self-antagonism at high concentrations.
    • A refined model of hPRL-receptor interaction is proposed, differing slightly from the hGH model.